SLRX stock forecast
Our latest prediction for Salarius Pharmaceuticals Inc's stock price was made on the Aug. 17, 2021 when the stock price was at 0.88$.
In the short term (2weeks), SLRX's stock price should outperform the market by 1.74%. During that period the price should oscillate between -10.47% and +17.69%.
In the medium term (3months), SLRX's stock price should outperform the market by 14.56%. During that period the price should oscillate between -39.34% and +56.54%.
Get email alertsCreate a solid portfolio with SLRX
About Salarius Pharmaceuticals Inc
salarius is an oncology based biotechnology company developing targeted treatments for patients who need them the most.
At the moment the company generates 3M USD in revenues.
On its last earning announcement, the company reported a loss of -0.32$ per share.
The book value per share is 2.16$
Three months stock forecastAug. 17, 2021
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
3M | 48.60% | -10M | -314.10% | -10M | -0.32 | - | - | 35M | 2.16 | -9M | - | -9M |